This trial is active, not recruiting.

Condition coronary artery disease
Sponsor Medstar Research Institute
Start date October 2009
End date July 2012
Trial size 800 participants
Trial identifier NCT01003795, P REWARDS


Single-center registry of patients treated with at least one Promus, everolimus-eluting, Stent, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Patients treated with at least one Promus, everolimus-eluting, Stent

Primary Outcomes

Evaluation of Major Adverse Cardiac Events (MACE) post Promus Stent implantation
time frame: Follow up

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients, male or female, >18 years of age - Patients who received at least one Promus drug-eluting stent at the Washington Hospital Center Exclusion Criteria: - N/A

Additional Information

Official title P-REWARDS (Promus - Registry Experience at the Washington Hospital Center, DES)
Principal investigator Ron Waksman, MD
Description Interventional cardiology was revolutionized by the invention of stents, initially with the bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus eluting stents have shown very promising results in randomized clinical trials, demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and comparable clinically-driven target lesion revascularization rates in comparison with sirolimus-eluting stents. While registry data is available from outside of the United States, it will be important to collect "real-world" data regarding the stent usage and outcomes in the United States. In this study we propose to follow patients who received at least one Promus® Stent for at least 1 year post initial stent implantation.
Trial information was received from ClinicalTrials.gov and was last updated in March 2013.
Information provided to ClinicalTrials.gov by Medstar Research Institute.